## Understanding the Epidemiological Context The stem provides two distinct measures: - **120 new TB cases** in 100,000 population during 2023 → This is **incidence** - **280 total TB cases** in 100,000 population at end of 2023 → This is **prevalence** The officer's goal is to **assess whether TB control efforts are reducing the disease burden** — i.e., evaluating the effectiveness of interventions over time. ## Why Incidence Trend Analysis is the Correct Approach **Key Point:** To evaluate the **effectiveness of disease control programs**, the appropriate measure is **incidence**, not prevalence. Incidence reflects new cases occurring in the disease-free population and is sensitive to changes in disease risk due to interventions. ### Incidence vs. Prevalence in Program Evaluation | Aspect | Incidence | Prevalence | |--------|-----------|------------| | **What it measures** | New cases in disease-free population | All cases (new + old) at a point in time | | **Reflects** | Current disease risk, effectiveness of prevention | Disease burden, need for treatment services | | **Responds to interventions** | Quickly (↓ new cases = ↓ incidence) | Slowly (affected by treatment duration, mortality) | | **Use in program evaluation** | **Best for assessing control effectiveness** | Better for resource planning | **High-Yield:** Incidence is the **gold standard metric for evaluating disease prevention and control programs** because it directly reflects whether interventions are reducing new disease occurrence. ## Why Comparing Incidence Over Time is the Next Step **Clinical Pearl:** TB control programs aim to reduce transmission and new infections. The incidence rate (120 per 100,000 in 2023) should be compared with: - Incidence in 2022, 2021, 2020 (trend analysis) - National TB incidence rate - State TB incidence rate - WHO targets for TB elimination If incidence is declining year-over-year, it indicates that TB control efforts (case detection, treatment, contact tracing) are working. If incidence is stable or rising, it signals the need for program intensification. ### Why Prevalence is Not the Answer Prevalence at the end of 2023 (280 per 100,000) reflects: - All cases diagnosed during 2023 (120 new cases) - Cases from previous years still alive and not yet cured (160 old cases) Prevalence is influenced by treatment success rates and patient survival, not just new disease occurrence. A declining incidence with stable prevalence might indicate good treatment outcomes, but it does not directly measure control program effectiveness. **Mnemonic:** **INCIDENCE for Intervention evaluation** — Incidence is the measure that changes first when you intervene. Prevalence lags behind because it includes the backlog of existing cases. [cite:Park 26e Ch 5]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.